bit.bio uses synthetic biology and combinatorial gene expression to precisely reprogram human stem cells into any cell type on demand. Their opti-ox technology enables deterministic, consistent cell identity coding, producing research-grade and therapeutic-grade human cells (neurons, cardiomyocytes, etc.) at scale.